Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
FEMS Microbiology Reviews|June 24, 2023
The never-ending battle between lactic acid bacteria and their phagesCécile Philippe, Jeffrey K Cornuault, Alessandra G de Melo, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 9, 2024
Evaluation of Hepatic Glucose and Palmitic Acid Metabolism in Rodents on High-Fat Diet Using Deuterium Metabolic ImagingViktoria Ehret, Usevalad Ustsinau, Joachim Friske, et al.
Applied and Environmental Microbiology|August 4, 2019
Lysogeny in the Lactic Acid Bacterium Oenococcus oeni Is Responsible for Modified Colony Morphology on Red Grape Juice AgarAmel Chaïb, Cécile Philippe, Féty Jaomanjaka, et al.
Microbiology Spectrum|August 12, 2025
Characterization of strictly lytic phages infecting Oenococcus oeni from Merlot wines and proposal of a new genusYasma Barchi, Florencia Oviedo-Hernandez, Amel Chaïb, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
FAPI Tracer en Vogue: Evaluating [68Ga]Ga-DATA5m.SA.FAPi for Molecular Imaging of Pulmonary FibrosisVictoria Weissenböck, Michaela Schlederer, Latifa Bakiri, et al.
EJNMMI Research|April 2, 2016
[(18)F]FE@SNAP-a specific PET tracer for melanin-concentrating hormone receptor 1 imaging?Cécile Philippe, Daniela Haeusler, Thomas Scherer, et al.
EJNMMI Radiopharmacy and Chemistry|January 10, 2025
Preclinical evaluation of the potential PARP-imaging probe [carbonyl-11C]DPQKatarína Benčurová, Theresa Balber, Victoria Weissenböck, et al.
Bulletin Du Cancer|May 10, 2015
[Morbidity of pelvic lymphadenectomy and para-aortic lymphadenectomy in endometrial cancer]Nicolas Agar, Anne-Cécile Philippe, Nicolas Bourdel, et al.
British Journal of Clinical Pharmacology|April 13, 2017
Effect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of (R)-[11 C]verapamil in elderly vs. young subjectsMartin Bauer, Beatrix Wulkersdorfer, Rudolf Karch, et al.
EJNMMI Radiopharmacy and Chemistry|June 12, 2018
Comparison of fully-automated radiosyntheses of [11C]erlotinib for preclinical and clinical use starting from in target produced [11C]CO2 or [11C]CH4Cécile Philippe, Severin Mairinger, Verena Pichler, et al.
Pageof 7